![Anders Nykjaer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anders Nykjaer
Fundador en Insusense ApS .
Cargos activos de Anders Nykjaer
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
University of Aarhus | Corporate Officer/Principal | - | - |
Insusense ApS
![]() Insusense ApS BiotechnologyHealth Technology Insusense ApS provides research and development in biotechnology. It conducts research and development on new medicines for treatment of diabetes, diabetes related diseases, and obesity. The company was founded by Anders Nykjær on April 19, 2010 and is headquartered in Copenhagen, Denmark. | Director Técnico/Científico/I+D | - | - |
Fundador | - | - |
Historial de carrera de Anders Nykjaer
Antiguos cargos conocidos de Anders Nykjaer.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Recepticon ApS
![]() Recepticon ApS Pharmaceuticals: MajorHealth Technology ReceptIcon is a biotech company based on the identification of novel receptors in the kidney that are responsible for renal uptake and nephrotoxity of therapeutic drugs. The company is focused on the development of receptor antagonists that prevent accumulation of therapeutics in the kidney. Such antagonists can be used as active pharmaceutical ingredients for reformulation of marketed nephrotoxic drugs thereby precluding their toxic side effects. | Director Técnico/Científico/I+D | 01/01/2001 | 23/03/2010 |
Fundador | 02/09/2009 | 23/03/2010 | |
Lundbeck Foundation
![]() Lundbeck Foundation Investment Trusts/Mutual FundsMiscellaneous Lundbeck Foundation maintains and expands the activities of the Lundbeck Group. It provides funding for scientific research. Its support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. The firm grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. The company was founded by Grete Lundbeck on March 4, 1954 and is headquartered in Copenhagen, Denmark. | Presidente | 02/09/2009 | - |
Formación de Anders Nykjaer.
University of Aarhus | Doctorate Degree |
Estadísticas
Internacional
Dinamarca | 5 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Doctorate Degree | 2 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Miscellaneous | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Recepticon ApS
![]() Recepticon ApS Pharmaceuticals: MajorHealth Technology ReceptIcon is a biotech company based on the identification of novel receptors in the kidney that are responsible for renal uptake and nephrotoxity of therapeutic drugs. The company is focused on the development of receptor antagonists that prevent accumulation of therapeutics in the kidney. Such antagonists can be used as active pharmaceutical ingredients for reformulation of marketed nephrotoxic drugs thereby precluding their toxic side effects. | Health Technology |
Lundbeck Foundation
![]() Lundbeck Foundation Investment Trusts/Mutual FundsMiscellaneous Lundbeck Foundation maintains and expands the activities of the Lundbeck Group. It provides funding for scientific research. Its support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. The firm grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. The company was founded by Grete Lundbeck on March 4, 1954 and is headquartered in Copenhagen, Denmark. | Miscellaneous |
Insusense ApS
![]() Insusense ApS BiotechnologyHealth Technology Insusense ApS provides research and development in biotechnology. It conducts research and development on new medicines for treatment of diabetes, diabetes related diseases, and obesity. The company was founded by Anders Nykjær on April 19, 2010 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Anders Nykjaer
- Experiencia